Expertise in
14
conditions

Ellen De Langhe

Leuven, VLG, BE 
Expertise in
14
conditions
Leuven, VLG, BE 

Overview

Ellen De Langhe practices practicing medicine in Leuven, Belgium.

Ms. De Langhe is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Myositis, and Antisynthetase Syndrome.

She is actively involved in clinical research, co-authoring 124 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Leuven, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

124 Total Publications

Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.
Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.
Journal: The New England journal of medicine
Published: July 29, 2026

Frequently Asked Questions about Ellen De Langhe

Is Ellen De Langhe a top-rated expert for Systemic Sclerosis (SSc)?

MediFind is an objective health platform that identifies experts based on real-world data. Ellen De Langhe is classified as an Distinguished expert for Systemic Sclerosis (SSc), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ellen De Langhe participate in research or clinical trials?

Yes. Ellen De Langhe has published 124 articles and abstracts on conditions like Systemic Sclerosis (SSc). You can view a list of Ellen De Langhe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. De Langhe's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile